Byron Carrasco
Foot & Ankle Surgery · Honolulu, HINPI 1356641476
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,963 of the $3,325 with a category attached, or 89.1%. 18 manufacturers reported payments, led by AbbVie at 27.1% of the total.
Across 102 payments — averaging $32.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$902
- Organogenesis Inc.$632
- Orthofix Medical, Inc.$398
- Integra Lifesciences Corporation$362
- Smith+Nephew$163
- Travere Therapeutics, Inc.$142
- plus $726 from 12 others
What the payments were for
- Food & beverage$2,96389%
- Other$36211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 40 | $902 |
| Organogenesis Inc. | 16 | $632 |
| Orthofix Medical, Inc. | 21 | $398 |
| Integra Lifesciences Corporation | 1 | $362 |
| Smith+Nephew | 3 | $163 |
| Travere Therapeutics, Inc. | 1 | $142 |
| AstraZeneca | 1 | $127 |
| Osiris Therapeutics Inc. | 1 | $120 |
| Amgen(2 entities) | 6 | $99 |
| Stability Biologics, LLC | 1 | $96 |
| Trimed, Inc. | 1 | $72 |
| Bone Support Inc. | 1 | $62 |
| Kowa Pharmaceuticals America, Inc. | 4 | $58 |
| Mimedx Group, Inc. | 1 | $32 |
| Solventum Corporation | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| IBSA Pharma Inc. | 1 | $13 |
| Baudax Bio Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$362
- LOKELMA$127
- TEFLARO$126
- ACTICOAT 4" X 4"$125
- ALLEVYN HEEL 10.5CM X 13.5CM CTN 5$125
- Iodosorb Ointment 40g USA$125
- COLLAGENASE SANTYL$125
- AVYCAZ$122
- Stravix$120
- Grafix$120
- GrafixPL$120
How this compares
Too few foot & ankle surgery providers in Hawaiito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole | 78 | $1,739 |
| Ciclopirox | 23 | $1,029 |
| Doxycycline Hyclate | 59 | $552 |
| Ammonium Lactate | 31 | $508 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $169 |
| Cephalexin | 13 | $122 |
| Ciprofloxacin Hcl | 16 | $110 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Honolulu
- Darren DayHonolulu$8K
- Gregory MorrisHonolulu$2K
- Caleb LazarreHonolulu$26
- Kari TanimotoHonolulu$17
- Alicia UnangstTripler Army Medical Center$17K
- Shaun ChangKailua$14K
- Lowell TongAiea$10K
- Victoria ScalaKailua Kona$5K
- David LeeLahaina$4K
- Jennifer LeeKailua$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.